EP-Compliant Lavender Oil for Pharmaceutical Applications:GMP Documentation Suite

2025-07-15 11:22

Title:  

EP-Compliant Lavender Oil for Pharmaceutical Applications:GMP Documentation Suite  

Content:  

Meeting European Pharmacopoeia 10.0 standards, Blue EyesBiotech’s medicinal lavender oil delivers quantified actives for evidence-basedformulations:  

- Anxiolytic Drugs: 39-43% linalool (validated in stressbiomarker reduction)  

- Topical Analgesics: Synergistic terpene profile withCOX-2 inhibition data  

- Inhalation Solutions: Particulate matter <0.1% (USP<788> compliant)  


GMP Manufacturing Protocols:  

- Class D cleanroom bottling  

- Validated sterilization filtration(0.22μm PTFE)  

- ICH Q1D accelerated stability data (36months)  


Regulatory Support Package:  

- EP Certificate of Suitability (CEP)drafting  

- IMPD modules for clinical trial materials

- Extractables/Leachables studies forinhalation devices  


Request EP monograph gap analysis:[email protected]  

Access pharmaceutical dossier:www.blueeyes-bio.com


Name:
Message:
Verification code:
Submit
Comment